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Consumption of food containing mercury has
been identified as a health risk. The U.S.
Environmental Protection Agency (U.S. EPA)
and the National Academy of Sciences recom-
mend keeping the whole blood mercury level
< 5.0 µg/L or the hair level < 1.0 µg/g. This
corresponds to a reference dose (RfD) of no
greater than 0.1 µg Hg/kg body weight per
day [Mahaffey and Rice 1998; National
Academy of Sciences (NAS) 2000].
Fish accumulate methyl mercury in their
tissues, where it becomes strongly bound.
Methyl mercury is not removed from ﬁsh tis-
sue by any practical cooking method
(Chicourel et al. 2001; Morgan et al. 1997;
U.S. EPA 1999).
Methyl mercury is absorbed on average
95% when consumed. From the blood-
stream, it is taken up by all tissues, with an
initial phase of distribution of 1–2 days after
a single dose (Clarkson 1997). It is excreted
predominantly in the feces but also in urine
and sweat. A conversion factor of 1:250 has
been used to convert hair to whole blood
(4.0 µg/L × L/1,000 g × 250 = 1.0 µg/g;
Clarkson 1997; Mahaffey and Rice 1998).
Methyl mercury can accumulate if con-
sumed at a greater rate than it is excreted. It
has a strong afﬁnity for sulfhydryl groups in
tissues and accumulates to a greater concen-
tration in brain, muscle, and kidney (NAS
2000).
Methyl mercury crosses the maternal to
fetal blood compartments, where it binds to red
blood cells and other fetal tissues. By the time
of parturition, cord blood is on average twice
that of the maternal blood concentration.
Individual studies have reported mother to
cord blood ratios much greater than 1:2
(Bjerregaard and Hansen 2000; Hansen et al.
1990; Vahter et al. 2000; Weiss 1994).
Methyl mercury easily crosses the
blood–brain barrier, where biotransformation
to inorganic mercury takes place. The
brain:blood concentration ratio when the ini-
tial distribution phase is completed is
between 10:1 and 5:1. Once in the central
nervous system, methyl mercury can be
demethylated to inorganic mercury. This lat-
ter form of mercury has a long half-life in
brain tissue and can be measured in years
(Clarkson 1997; Davis et al. 1994; Pedersen
et al. 1999). The average half-life in blood for
methyl mercury in adults is 70 days, in chil-
dren 90 days, and in lactating women 46 days
(Swartout and Rice 2000).
In this article we report the dietary habits
and corresponding mercury levels of patients
in a San Francisco, California, internal medi-
cine practice who consume excess mercury
through fish, many of whom had mercury
levels at or greater than the U.S. EPA’s RfD.
Methods
All patients in a general internal medicine
practice in San Francisco who came for an
ofﬁce visit during a 1-year period were evalu-
ated for risk of mercury excess. The practice is
mostly middle to higher income patients.
Patients were asked to estimate from a list of
ﬁsh the average number of times per week or
month they ate each fish, and the length of
time they were on their current diet. The
patients were given an opportunity to add
other fish to the list. The average restaurant
serving of fish in five local restaurants that
subjects frequented was reported to be
5.0–8.0 ounces (150–227 g). Patients were
asked to estimate the portion size that they
consumed per serving. A reference amount of
170 g or 6-oz can of tuna was used to help
patients estimate their intake. Some patients
gave a range for their frequency of intake.
The ranges were averaged based on a 28-
day month. Portion size was converted to a
size of 5.0–8.0-oz (150–227 g) portions per
month. Canned tuna was measured in 6-oz
(170 g) cans per month. To separate tuna
from lobster or crab, sushi and shellﬁsh were
placed into separate categories. To estimate
risk of mercury exposure, portion size in
grams for each type of fish meal eaten by
patients was multiplied by the average 
mercury content of that fish, as determined
by published tables [Food and Drug
Administration (FDA) 1995; Mahaffey and
Rice 1998]. Table 1 shows mercury data used
for the 11 most commonly eaten ﬁsh for this
study population.
Those whose dietary history suggested
their mercury intake was at or greater than
the RfD for their average monthly intake,
0.1 µg/kg body weight per day, were asked
to be screened with a whole blood mercury
test. Patients were also tested if they had
symptoms consistent with methyl mercury
excess regardless of estimated dietary levels
of mercury. These symptoms, such as
fatigue, headache, decreased memory,
decreased concentration, and muscle or joint
pain, have been delineated in large epidemi-
ologic studies as symptoms of mercury
excess (Fukuda et al. 1999; Harada 1995).
The criteria for symptoms were that the
patients had sought health care for symp-
toms or that symptoms affected daily living.
Patients were excluded if fish were obtained
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ﬁsh caught in the San Francisco Bay or local
rivers and streams.
Other sources of mercury exposure were
investigated through questionnaires and phys-
ical exams: silver/mercury dental amalgams;
vaccine records; occupational exposure; home
environment exposures; supplements such as
fish oils, herbs, and medications; cosmetics;
drinking water; and other foods.
This study was conducted in a private
medical ofﬁce, and therefore patients chose a
variety of clinical labs based on insurance
criteria and convenience.
Twelve drawing stations were involved in
collecting the specimens. All specimens were
collected in a royal blue-top, metal-free tube
with ethylenediamine-tetraacetic acid di-
sodium (EDTA-Na2). The testing was per-
formed at seven laboratories for a total of
225 tests. Specialty Labs of Santa Monica,
California, performed 84% of the whole
blood tests. Most (98%) of the blood analyses
were performed by four labs, using inductively
coupled plasma–mass spectrometer (ICP-MS)
model HP4500 ICP-MS (Agilent, Foster City,
CA). Controls were whole blood I (lot M98-
07; Centre of Toxicology of Québec, Sainte-
Foy, Québec, Canada) and whole blood II (lot
M98-02). Low control standard deviation
(SD) was ± 0.36 µg/L with a coefficient of
variation of 11.7%; high control SD was
± 1.12 µg/L with a coefﬁcient of variation of
8.4%. Dynamic range of the assay is 2.0–800
µg/L. Specialty Labs participates in the Quebec
ICP-MS external proﬁciency program. They
are licensed by California and by California
laboratory improvement amendments.
All study patients with unexplained symp-
toms or mercury levels higher than 5.0 µg/L
whole blood or 1.0 µg/g hair were instructed to
either stop all ﬁsh for 6 months or eat only ﬁsh
that are known to be low in mercury, such as
salmon, tilapia, sole, sardines, or small shellﬁsh.
Results
We evaluated 720 individuals from March
2000 to March 2001. Fewer than 20 patients
who met the criteria for testing declined testing.
We tested 123 patients: 93 females and
30 males. All but one lived in San Francisco
or the surrounding bay area. Among the
occupations held by the study patients were
physicians, scientists, banking industry pro-
fessionals, business owners, internet execu-
tives, lawyers, investment brokers, and
corporate executives. Retirees and homemak-
ers were also included. Seven children are also
represented in the survey.
One hundred sixteen patients had a whole
blood level as their initial test; seven patients
had a hair level analysis. Of the blood levels
tested, 103 (89%) were ≥ 5.0 µg/L, 63 (54%)
were ≥ 10 µg/L, 19 (16%) were ≥ 20 µg/L, and
4 were > 50 µg/L. The mean was 14.0 µg/L.
Hair levels ranged from 1.55 to 14.81 µg/g.
Four adult patients had received thimerosal-
containing vaccinations within 60 days before
testing. The minimum time intervals from
vaccine to mercury test for these patients
ranged from 14 to 49 days. Their levels ranged
from 9.9 to 35.4 µg/L. The minimum time
interval for children from vaccine to mercury
test was 12 months.
The number of silver/mercury dental
amalgams seen in the patients on this survey
ranged from 0 to 14. Most patients who had
ﬁllings had gold or composite. Some patients,
including one with a mercury level of 76.0
µg/L, reported having all amalgam removed
at least 2 years before testing.
Sushi consisted of multiple combinations,
including ahi, yellow tail, mackerel, salmon,
eel, and sea urchin. Many patients reported eat-
ing only ahi as sushi. Shellfish consisted of
shrimp, prawns, crab, mussels, oysters, and scal-
lops. Only two patients reported eating lobster.
Nearly all sashimi was in the form of ahi.
Eighty-nine of the 123 patients were statis-
tically analyzed. Specialty Labs performed 90%
of the tests; 34 were excluded from further sta-
tistical analysis for the following reasons: some
patients were unable to recall their diet, hair
analysis was done instead of a blood level,
patients were consuming ﬁsh oil supplements
that may contain mercury, and some patients
stopped fish consumption or delayed testing
(one patient had stopped eating fish for 2
months and had a blood concentration of 9.0
µg/L, whereas two others delayed 2–3 weeks
and had levels of 13 and 11 µg/L). All other
patients obtained their initial test before or
within a few days of stopping ﬁsh consump-
tion. The seven children were not used for sta-
tistical analysis because of the increased half-life
compared with adults as well as their greater
serving size:body weight ratio compared with
adults. Two patients consumed noncommer-
cially caught ﬁsh. Although both individuals
caught these ﬁsh in federal waters, they did not
have a commercial license, so their data were
not used for statistical analysis. Their mercury
levels were 4.6 and 12.9 µg/L.
Statistical analyses of baseline levels of mer-
cury in 89 adults revealed the following: The
level of mercury ranged from 2 to 89.5 µg/L for
the 89 subjects. The mean level was 14.5 µg/L,
and the median was 11.2 µg/L; 82 subjects had
levels greater than 5 µg/L, and 16 subjects had
levels greater than 20 µg/L. There was no dif-
ference in the distribution of mercury level in
men and women. The mean for 66 women was
15 µg/L (SD = 15), and for 23 men the mean
was 13 µg/L (SD = 5). Ages ranged from 27 to
87 years (median age, 49 years; mean age, 50
years), and a slight increase of mercury level
with age was not statistically significant
(increase of 0.15 µg/L per year; p = 0.21).
Seventy-seven subjects reported the number of
years they had been on their current diet. The
mean was 9.3 years (median = 6 years), with a
range from 1 to 30 years. Mercury levels
decreased slightly with diet years, but the
decrease was not statistically significant
(decrease of –0.06 µg/L per year; p = 0.8).
Subjects consumed 30 different forms/
types of fish. Table 2 shows correlations
between ﬁsh consumption and mercury levels
for fish consumed by 20 or more subjects.
Swordfish had the highest correlation with
mercury level (Pearson correlation = 0.71, p =
0.001). This was the only ﬁsh with a signiﬁ-
cant positive correlation with mercury level.
Red snapper and sole consumption correlated
negatively with mercury level, but only red
snapper was statistically significant (Pearson
correlation = –0.39, p = 0.03). No other cor-
relations were significant. Because multiple
factors that univariately affected mercury level
were not seen, multivariate analysis was not
performed. Cause and effect regarding symp-
toms is not addressed in this article.
Sixty-seven patients were followed over
time with serial blood levels after stopping or
greatly reducing intake of ﬁsh with moderate
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Table 1. Average methyl mercury level in fish as
reported by the Mercury Study Report to Congress
(Mahaffey and Rice 1998).
Species Average wet weight Hg (µg/g)
Sea bass 0.157
Crab 0.117
Flounder 0.092
Halibut 0.25
Lobster 0.232
Salmon 0.035
Scallops 0.042
Shark 1.327
Shrimp 0.047
Snapper 0.25
Swordﬁsh 0.95
Ahi 0.38a
Tuna
Average 0.206
Light skipjack 0.13
Light yellow 0.218
Albacore 0.20
aData from FDA (1995).
Table 2. Fish consumption and correlation with
mercury.
Pearson
Fish No. subjects % No. mealsa correlation
Canned tuna 69 78 3.65 –0.02
Salmon 66 74 4.60 0.21
Swordﬁsh 64 72 1.94 0.71
Halibut 60 67 2.00 0.04
Ahi steaks 57 64 2.74 0.20
Sea bass 56 63 1.54 –0.04
Sushi 47 53 2.60 –0.01
Red snapper 33 37 1.32 –0.39
Shellﬁsh 33 37 2.54 0.11
Sashimi 24 27 2.03 0.33
Sole 24 27 2.56 –0.36
aAverage per month.to high mercury content. Mercury levels
declined rapidly in the ﬁrst 3 weeks followed
by a slower reduction over time. All but two
patients reduced their level to < 5.0 µg/L by
41 weeks. These two individuals continued to
eat large predatory fish. Reduction in levels
over time is significant (p < 0.0001). The
average rate of decline for all 67 patients with
two or more mercury measurements is 4.4%
per week. The decline appears linear on a log
(Hg) scale, but there are at most four time
points for any patient. Most declines are
based on two measurements. Figure 1 shows
blood mercury levels in 21 subjects with three
or more measurements over time. The thick
black line shows an exponentially declining ﬁt
to data from all 67 subjects. The horizontal
dashed line is at 5 µg/L.
Seven children are represented in this sur-
vey (Table 3), ranging in age from four months
to 12 years. Exposure from ﬁsh was from 10
different types. Tuna accounted for ﬁve of the
types of fish meals consumed. The parents
reported sushi and sashimi to be primarily ahi.
Two of the children did not eat ﬁsh.
One child, a 50-lb, 7-year-old boy, had
an initial hair level of 14.81µg/g. He had
been eating ﬁsh most of his life, and had been
consuming his current regimen of albacore
steaks, ahi steaks, canned tuna, and salmon
for the last 4 years. Before this, the mother
was unable to estimate how much fish was
eaten and what types. In 1999, he ate king
mackerel twice a week for 6 months. After ﬁsh
consumption was stopped, hair and blood lev-
els began to decline. At 31.86 weeks without
ﬁsh, his hair level was 0.89 µg/g (Figure 2).
Subject 81, whose initial blood level was
26 µg/L, is a 17-month-old boy who ate small
adult portions of eight servings of salmon and
eight servings of sole every month. He also
breast-fed twice a day while his mother’s level
was 9.0 µg/L (Table 2). His mother ate the
same ﬁsh meals, only slightly larger portions,
whereas the father ate closer to 8-oz portions
and his level was 8.0 µg/L. After not eating
fish for 3 months, the boy had a 2-in-long
hair sample taken at the scalp, which had a
mercury level of 4.27 µg/g. At 4 months, his
hair level was 2.63 µg/g. A follow-up blood
level at 8 months was < 5.0 µg/L.
A 4-month-old girl with a hair level of
3.06 µg/g did not eat fish or have any
thimerosal. Her exposure appeared to be
solely from her mother, whose blood level
while breast-feeding was 16.5 µg/L.
Two gynecologists from our facility
screened 22 of their patients very early in preg-
nancy for a short period of time. The gynecol-
ogists did not use the RfD to guide them in
their testing, but the patients were consumers
of commercial fish. A whole blood level was
obtained on all of these patients; 13 patients
had mercury levels < 5.0 µg/L, 2 were between
5.0 and 9.9 µg/L, and 7 were between 10.0
and 19.9 µg/L. Specialty Labs performed all
lab tests on these patients (Figure 3).
Specialty Labs conducted an internal labo-
ratory survey in 2002 of 66 random specimens
submitted to their lab for copper and zinc
analysis for nutritional evaluation (collected in
EDTA-Na2 tubes and run on the same
machine as the mercury analysis). Specialty
Labs receives specimens from a broad range
of areas across the United States. Mercury lev-
els on those specimens ranged from 0 to
18.5 µg/L. The average was 1.9 µg/L, with an
SD of 2.7; 94% were below 5.0 µg/L.
Discussion
In this study we have identiﬁed a subpopula-
tion at risk for mercury excess. All individuals
were able to give the number of years that
they had been choosing large predatory fish
for regular consumption. This change in ﬁsh
consumption pattern usually followed a life
change, such as a new job, marriage, gradua-
tion from college, moving to the San
Francisco Bay area, or achieving a higher
income from other means. Higher economic
status and education level appear to be risk
factors. Most individuals did not eat ﬁsh as an
infant or child, did not prefer a strong fish
flavor, and did not like bones in their fish.
They were also not deterred by the price of
their ﬁsh. This study conﬁrms the hypothesis
in the Mercury Study Report that “con-
sumers not limited by income, who consume
a large portion of their dietary protein from
ﬁsh, especially if they choose large predators
such as swordﬁsh, sea bass, etc., would be at
risk for exposure to mercury” (Mahaffey and
Rice 1998).
The U.S. Centers for Disease Control and
Prevention (CDC) estimated the U.S. mean
total blood mercury level to be 0.3 µg/L for
children ages 1–5 and 1.3 µg/L for women
ages 16–49 (CDC 1999). The mean level for
women in our survey was 10 times that of
mercury levels found in this recent CDC
population survey (CDC 1999). Our survey
found that children had > 40 times the
national mean.
Fish consumption was positively correlated
with mercury elevations in the study patients.
Swordﬁsh had the highest positive correlation,
but 19 adult patients (21%) had levels > 5.0
µg/L and did not eat swordﬁsh. None of the
children were currently eating ﬁsh listed on the
U.S. Food and Drug Administration (FDA)
advisory (tile fish, swordfish, king mackerel,
and shark), yet all ﬁve who ate ﬁsh had levels
exceeding the RfD. Further advisories would
be needed to reduce mercury accumulation in
high-end consumers.
Snapper consumption correlated nega-
tively with mercury level even after adjust-
ment for swordfish consumption. Recently,
the FDA collated mercury samples of fish
from four surveys conducted between 1978
and 2000. Ten fish labeled as red snapper
were tested. The mean was 0.60 µg/g, with a
range of 0.07–1.46 µg/g (FDA 2001). A
recent investigative report on fish that
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Figure 1. Blood mercury levels in 21 subjects with
three or more measurements over time. Levels for
individual patients are designated by straight lines.
The thick line shows an exponentially declining ﬁt
to data from all 67 subjects. The horizontal dashed
line is at 5 µg/L.
Table 3. Mercury levels and diets of seven children.
Fish meals per month
Patient M/F Time on Mercury Breast- Sea Shell- Albacore Ahi Canned tuna Mother’s
no.a ratio Age diet levelb feeding Halibut Sashimi bass ﬁsh Sushi steaks steaks (6-oz cans) Salmon Sole levelb
2F 12 5 yr 11.2 µg/L 6 3 18.5 µg/L
52 F 4 mo 3.06 µg/g Only 16.5 µg/L
67 F 5 1 yr 13.0 µg/L 87 .4 µg/L
69 M 3 < 5.0 µg/L 7.4 µg/L
81 M 17 mo 6 mo 26 µg/L 2×/day 889.0 µg/L
104 F 11 9 yr 3.5 µg/g 1 3 3 8 2 3 8.0 µg/L
117 M 7 4 yr 14.81 µg/g 4 2 2 6 4 1.65 µg/g
Abbreviations: F, female; M, male; mo, months; yr, years. 
aPatients 67 and 69 are siblings. bµg/L is a whole blood level; µg/g is a hair level. included red snapper found that of 11 super-
market samples labeled as red snapper, only
four actually were ([Anonymous.] 2001). An
uncertainty exists as to the mercury content of
the ﬁsh sold as red snapper.
Individuals showed large variability in
mercury levels even after adjustment for
dietary history. Factors that can account for
this are individual variation in kinetics among
different individuals, a wide range of mercury
levels in the ﬁsh consumed, the timing of test
in relation to the ﬁsh consumed, and inaccu-
racy of dietary recall.
Variation among laboratories could also
be a source of concern, but the SD reported
for whole blood mercury levels by these labs of
< 1.0 µg/L for the low control and < 2.0 µg/L
for the high control is small compared with
the measured levels in our subjects. No clus-
tering of data or inconsistencies were seen
with respect to laboratory values. The five
highest analyses reported in this study were
performed at ﬁve different labs. All ﬁve sub-
jects consumed swordfish. The subject with
the highest mercury level of 89.5 µg/L ate the
most servings of swordﬁsh, at an average of 14
servings per month. Four of the ﬁve subjects
ate ahi steaks also. These high levels in the ﬁve
subjects are consistent with the mercury levels
reported in the ﬁsh being consumed.
There is no standardization for clinical labs
in the interpretation of results. Some labs give
occupational levels considered “safe” and will
give such statements as normal is < 13 µg/L at
the end of the shift at the end of a work week.
For those clinicians trying to assess their
patients using the current RfD for intake of
methyl mercury, this makes interpretation of
the results unclear. A whole blood mercury
analysis tests for the concentration of the ele-
ment regardless of its chemical form. The test is
reproducible between labs within the SD of the
machine performing the analysis. For labs that
give the occupational level, the clinician has to
write on the requisition “titer to < 5.0 µg/L.”
Many patients in this study took longer
than 21 weeks to reduce blood levels to
< 5.0 µg/L and or hair levels to < 1.0 µg/g.
Their high consumption of mercury is most
likely causing accumulation, and this can
pose a health risk. Accumulation in different
organs can be quite variable. As an example, a
recent report on trace elements in idiopathic
dilated cardiomyopathy (IDCM) showed an
increase of > 10,000 times more mercury in
myocardial tissue than in skeletal muscle in
all patients with this condition. The mean
mercury level in cardiac muscle was 22,000
times higher in IDCM patients than in con-
trol subjects (178.4 µg/g vs. 0.008 µg/g;
Frustaci et al. 1999).
Recent studies have also found associations
between exposure to methyl mercury and
impairments of the immune and reproductive
systems. Adverse effects occurred with even
modest elevations of mercury (Fukuda et al.
1999; NAS 2000).
A study of Finnish men evaluated the
effects of mercury on coronary heart disease.
Men in the highest tertile (= 2.0 µg/g) of hair
mercury content had a 2.0-fold (95% conﬁ-
dence interval, 1.2–3.1; p = 0.005) age- and
coronary heart disease-adjusted risk of anterior
myocardial infarction and a 2.9-fold (95%
confidence interval, 1.2–6.6; p = 0.014)
adjusted risk of cardiovascular death com-
pared with those with a lower hair mercury
content (Salonen et al. 1995). A follow-up in
the year 2000 conﬁrmed that ﬁsh-oil–derived
fatty acids reduce the risk of acute coronary
events; however, a high mercury content in
fish could attenuate this protective effect
(Rissanen et al. 2000).
The American Heart Association pro-
motes an increase of omega-3 fatty acids in
the diet but encourages a variety of sources
such as fatty fish, flaxseed, flaxseed oil,
canola oil, soybean oil, and nuts. They rec-
ommend at least two servings of fatty fish
per week to confer cardioprotective effects
(Krauss et al. 2000).
If the data on cardiovascular risk from the
Finnish studies hold for additional populations,
the blood mercury levels achieved by most of
our study population indicate a general adult
population at risk. Given that ﬁsh consump-
tion is promoted to reduce the risk of coronary
heart disease, the need to improve information
and publicity on the risks entailed is great.
Multiple epidemiologic studies have been
ongoing in other countries, to study the
effects of low-level prenatal exposure to
methyl mercury. Adverse effects in children are
judged to occur when, during pregnancy, the
mother’s blood contains more than 15 µg/L,
equivalent to 4–5 µg/g in hair (Mahaffey
1999). Our survey demonstrates the need for
prepregnancy screening in patients with high
consumption of ﬁsh.
Given the long time intervals between
vaccines and blood test for our study, the
contribution of ethylmercury was negligible
compared with diet (Stajich et al. 2000).
Similarly, the mercury contribution from sil-
ver/mercury dental amalgams for our study
population was insignificant compared with
diet (Kingman et al. 1998).
The patients in the study were consistent
in their consumption patterns. They con-
sumed ﬁsh purchased at certain markets and
restaurants on a regular basis. Only a few
patients had some variation at times. Most
patients had the same diet when they traveled
and tended to visit coastal areas. It would be
expected that places such as New York;
Maine; Florida; Hawaii; Martha’s Vineyard,
Massachusetts; and Los Angeles, Monterey,
Santa Cruz, and San Diego, California, could
demonstrate similar data. Because we were
trying to determine the cause of symptoms in
the study patients, we took a dietary history
that encompassed the entire year. Patients
were also asked to give an average estimate of
intake and how long they were on their cur-
rent diet. This consumption pattern appeared
to be part of a lifestyle.
Cause and effect regarding symptoms was
not fully addressed in this study for the fol-
lowing reasons. A chart review of symptoma-
tology on all patients presenting to the ofﬁce
in the 1-year period of the study was not
done. Therefore, a comparative analysis for
the purpose of controls is not available. Many
patients who present to their doctor have
symptoms that may be caused by other con-
ditions. It is difficult to determine whether
mercury is causing or exacerbating these
symptoms, especially in cases of autoimmune
phenomena, chronic fatigue syndrome,
fibromyalgia, depression, sinusitis, coronary
artery disease, and menopause, to name but a
few, where there is either a possible link to or
an overlap of symptoms with mercury expo-
sure. Second, the subjective nature of symp-
toms makes standardization difficult. Last,
because only mercury was tested in these
individuals, other contaminants responsible
for symptoms cannot be ruled out. Often the
clinician recommends elimination diets to
establish whether the patient is affected by an
exposure. It is important to demonstrate the
normalization of blood mercury levels for
clinicians who may want to try this as a diag-
nostic approach for certain individuals.
In conclusion, in this 1-year survey of an
internal medicine practice in San Francisco,
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Figure 2. Hair mercury decline in a 7-year-old boy.
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California, a substantial fraction of patients
had diets high in ﬁsh consumption. Of these,
a high proportion had blood mercury levels
exceeding the maximum level recommended
by the U.S. EPA and National Academy of
Sciences. Women of reproductive age and
pregnant women were found to have levels
considered unsafe for the developing fetus.
Mercury levels in peripheral blood and hair
correlated with ﬁsh consumption, particularly
swordﬁsh. When subjects abstained from ﬁsh,
these high levels of mercury were easily
reduced, but this took longer than 21 weeks
for many individuals.
Because ﬁsh consumption is promoted as
preventing heart disease and as good nutri-
tion, we might expect to see patients who
have excess fish intake showing side effects
caused by the contaminants that are present.
Therefore, dietary histories that encompass ﬁsh
consumption should become part of a compre-
hensive health screening to identify those at
risk for mercury accumulation. Likewise, test-
ing of mercury content in ﬁsh needs to con-
tinue. The results and advisories should be
readily available where ﬁsh are sold to reduce
the risk of mercury excess and accumulation
during a lifetime of ﬁsh consumption.
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